The Medical Joyworks Monthly

 

Connect to MJ's thriving community

Issue #21 (June 2021)

FROM OUR CEO

Dear Reader,

In July we celebrate one year of Clinical Odyssey, our flagship product that makes clinical skills improvement easier for students and young professionals.
Clinical Odyssey brings together all of our learning titles into one user-friendly platform, plus discussion boards carefully moderated by our physician team. It also sets the stage for easily providing more great clinical content to our customers.

As part of our anniversary celebration, we are releasing a completely revamped Clinical Odyssey. In fact, my team has been working hard over the past four months in order to go live with this new version one month ahead of schedule!

Some of the more visible improvements that we are introducing include:
  • a cleaner design for easier navigation and friendlier mobile experience,
  • improved content cataloging for more convenient search,
  • new security features for better user account and data protection,
  • improved centralized/decentralized discussion board access for faster engagement,
  • more payment options for greater access by students and physicians worldwide, and
  • a new free subscription option with up to 90 learning modules for more product trial flexibility by yet-to-become customers.
Of course, new and updated content will continue to become available regularly, as always. 

Our hope with this product upgrade is that we can further deliver direct benefits to our customers, partners, suppliers, additional stakeholders, and you. The revenues from our sales not only support our day-to-day operation. They also allow us to invest in technologies, design, and content production capabilities.

But more importantly, Clinical Odyssey lets us remain an independent medical learning provider—offering neutral, unbiased, up-to-date, and accessible content of the highest quality for medical practitioners worldwide.

So, please, enjoy this latest version of Clinical Odyssey! And let us know what you think.

Sincerely,

Dr. Nayana Somaratna,
CEO & Co-Founder,
Medical Joyworks

MEET YOUR IMB

International Medical Board Members

Name: Dr. Gilberto Heitor Moschetta MD
Speciality: Internal Medicine, Cardiology, Echocardiography
Designation: Attending Physician
Work institute: São Marcos Medical Society, São Marcos - RS, Brazil
Graduated from: Faculty of Medicine, Federal University of Rio Grande do Sul, Brazil
What attracted you to your specialty?
While in university, I was not so interested in cardiology. In fact, I was close to some rheumatologist friends and attracted to endocrinology — since all the way back in high school! But at the very end of my medical training I learned of a job opportunity that involved cardiology practice and stress testing. I was looking for work, so a very fast road change ensured, and... ta da! Here I am, a cardiologist.

What have you learned about your specialty solely from experience?
First of all, people are not interested in prevention of disease. They are attracted to rapid and magical solutions. So it becomes very difficult to influence them. We cardiologists have a hard time competing against online advertisers, neighbors, and relatives, specialists in every disease and capable of questioning your prescription. They always have “good reasons” to not listen to us.

What is a common misconception associated with your field of study?
The most common misconception related to what I mentioned in the previous question. People often think: “Hey, this is just the same as with me!” And with this attitude, they end up listening to their pharmacy attendant, the sister-in-law, or the person who casually connects with them via social media. “All these people know all about my condition. The doctor knows nothing.”

What is your biggest research interest today?
I do not have any specific interest. However, echocardiography is the most studied area of practical application these days.

In your opinion, what is the greatest challenge in your field today?
I sincerely believe that the greatest challenge is to make people realize that science is the best way we have to fighting disease and improving our quality of life.

What will be a game-changer innovation in your field?
Hypertension control is the very enemy I face today. A drug that could control the severe stages of the disease, with single dosage and no significant side effects, would be great!

How has MJ helped advance your professional objectives (in terms of teaching, research, management, personal development, etc.)?
Medical Joyworks helped me improve simply by giving me enough content to study more and more. Every scenario is a challenge that needs to be thoroughly understood before one can continue. For students, this is great. Now, as a reviewer I have the opportunity to fully revise a disease and its comorbidities, refreshing my knowledge easily.

DOCTORS' LOUNGE

Q&As from our user community

Clinical Sense: Bitten (Dog Bite)

Q: When is anti-rabies vaccination required immediately after a dog bite? When can we wait and supervise the animal instead?
A: Rabies post-exposure prophylaxis (PEP) should be administered to all persons exposed to a potentially rabid dog. This includes both administration of rabies immunoglobulin, and vaccination at days 0, 3, 7, and 14 after exposure. 

Immediate PEP is not necessary if the dog does not have signs of rabies infection (e.g., loss of appetite, dysphagia, abnormal behavior, ataxia, paralysis, altered vocalizations. or seizures). Such dogs can be observed for 10 days following exposure; and if they  develop symptoms, PEP should then be administered to the exposed person as soon as possible.

In cases where the dog cannot be observed (e.g., if it escapes and cannot be located), local public health authorities should be consulted; and immediate PEP administration considered.

For more information please see the following article:
https://www.aafp.org/afp/2014/0815/p239.html
If you would like to play this scenario or join the conversation, go to the Clinical Sense app in your mobile device.

Prognosis: Your Diagnosis: Difficult to swallow (Esophageal cancer)

Q: Shouldn't we consider a pharyngeal pouch in the differential diagnosis of this patient with progressive dysphagia? In that case, wouldn't a barium swallow be preferred over endoscopy?
A: Pharyngeal pouches are indeed part of the differential diagnosis of dysphagia; and a pharyngeal pouch would be compatible with the dysphagia, regurgitation, and weight loss seen in this patient. However, a point against this diagnosis is the patient's age—he is only 54 years old; pharyngeal pouches are mostly encountered in persons over 70 years of age.

It is also true that pharyngeal pouches are readily identified on barium studies. However, in this patient's case, an esophageal malignancy is still clinically more likely—and therefore, upper gastrointestinal endoscopy is probably a better first investigation.
If you would like to play this scenario or join the conversation, go to the Prognosis: Your Diagnosis app in your mobile device.

IN CASE YOU MISSED THEM

Recently released stories

Surgery
Dilated - Play it free online
Medicine
Stopped II - Play it in Clinical Odyssey
Medicine
Ingested 2 - Play it in Clinical Odyssey
Medicine
Veiled - Play it free online
Medicine
Totally confused - Play it in Clinical Odyssey
Medicine
Splintered - Play it in Clinical Odyssey
Obstetrics & gynecology
Gestational Diabetes Mellitus - Read it free online
... and more.
That's all for now!

Tell us what you think or share valuable insights with the community by writing to us at: penelope@medicaljoyworks.com.

Website
Facebook
Twitter
LinkedIn

You are receiving this email because you requested to be kept informed about our activities or because you asked to be added to our email mailing list.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Our mailing address is:
4023 Kennett Pike #55630, Wilmington, DE 19807, United States of America

Our website is:
www.medicaljoyworks.com

Copyright © Medical Joyworks LLC, 2021. All rights reserved.